No Data
No Data
Twining Biotech: Report for the first quarter of 2025
Yili Chuanning Biotechnology Co.,Ltd. (SZSE:301301) Looks Inexpensive But Perhaps Not Attractive Enough
Chuan Ning Biology: Yili Chuanning Biotechnology Co., Ltd. 2024 Annual Report
Chuan Ning Biology: Summary of the 2024 Annual Report of Yili Chuanning Biotechnology Co., Ltd.
Kewell Bio (301301.SZ): Will gradually release the production capacity of the synthetic biology base this year.
On February 25, Glonghui reported that Chuan Ning Biotechnology (301301.SZ) stated on the investor interaction platform that the company will gradually release the production capacity of the synthetic biology base this year, and its revenue share will also increase.
Is Yili Chuanning BiotechnologyLtd (SZSE:301301) Using Too Much Debt?